Inventor

SCHNEIDER JEAN-MARIE

FR15 patents

⚠️ This page may combine multiple inventors who share the name “SCHNEIDER JEAN-MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TREMEAU PHARMACEUTICALS INC

5 patents

US10987337B2Apr 27, 2021

QUANTUM GENOMICS

3 patents

US9487477B2Nov 8, 2016

Crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

QUANTUM GENOMICS0 citations46

US9340497B2May 17, 2016

Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid)

QUANTUM GENOMICS1 citations46

US9278921B2Mar 8, 2016

Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

QUANTUM GENOMICS0 citations46

PROD CHIM AUXILIAIRES ET DE SYNTHESE

2 patents

US9598350B2Mar 21, 2017

Process for preparing cinacalcet and pharmaceutically acceptable salts thereof

PROD CHIM AUXILIAIRES ET DE SYNTHESE0 citations39

US9290439B2Mar 22, 2016

Process for preparing cinacalcet and pharmaceutically acceptable salts thereof

PROD CHIM AUXILIAIRES ET DE SYNTHESE0 citations39

BIAL PORTELA & CA SA

1 patent

US10059696B2Aug 28, 2018

Process for preparing 1,3-dihydroimidazole-2-thione derivatives

BIAL PORTELA & CA SA0 citations49

BELIAEV ALEXANDER

1 patent

US9346751B2May 24, 2016

Process for preparing 1, 3-Dihydroimidazole-2-Thione Derivatives

BELIAEV ALEXANDER0 citations46

BALAVOINE FABRICE

1 patent

US9187418B2Nov 17, 2015

Method for the preparation of (3S, 3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid)

BALAVOINE FABRICE0 citations38

PRODUCTS CHIMIQUES AUXILIAIRES

1 patent

US7619116B2Nov 17, 2009

Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation

PRODUCTS CHIMIQUES AUXILIAIRES0 citations28

CHOUIPPE SNELLA

1 patent

US8592601B2Nov 26, 2013

Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer

CHOUIPPE SNELLA0 citations25

SCHNEIDER JEAN-MARIE

TREMEAU PHARMACEUTICALS INC

Purified forms of rofecoxib, methods of manufacture and use

Purified forms of rofecoxib, methods of manufacture and use

Purified forms of rofecoxib, methods of manufacture and use

Purified forms of rofecoxib, methods of manufacture and use

Purified forms of rofecoxib, methods of manufacture and use

QUANTUM GENOMICS

Crystalline phase of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid)

Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

PROD CHIM AUXILIAIRES ET DE SYNTHESE

Process for preparing cinacalcet and pharmaceutically acceptable salts thereof

Process for preparing cinacalcet and pharmaceutically acceptable salts thereof

BIAL PORTELA & CA SA

Process for preparing 1,3-dihydroimidazole-2-thione derivatives

BELIAEV ALEXANDER

Process for preparing 1, 3-Dihydroimidazole-2-Thione Derivatives

BALAVOINE FABRICE

Method for the preparation of (3S, 3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid)

PRODUCTS CHIMIQUES AUXILIAIRES

Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation

CHOUIPPE SNELLA

Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer